pargyline has been researched along with Vertigo in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| OLTMAN, JE | 1 |
| FRIEDMAN, S | 1 |
| KOHN, RM | 1 |
| HORLER, AR | 1 |
| WYNNE, NA | 1 |
3 other studies available for pargyline and Vertigo
| Article | Year |
|---|---|
PARGYLINE IN THE TREATMENT OF DEPRESSIVE ILLNESSES.
Topics: Antidepressive Agents; Antihypertensive Agents; Depression; Depressive Disorder; Hypotension; Imipra | 1963 |
NOCTURNAL ORTHOSTATIC SYNCOPE IN PARGYLINE THERAPY.
Topics: Antihypertensive Agents; Erectile Dysfunction; Humans; Hypotension; Hypotension, Orthostatic; Male; | 1964 |
HYPERTENSIVE CRISIS DUE TO PARGYLINE AND METARAMINOL.
Topics: Autonomic Nervous System Diseases; Drug Synergism; Drug Therapy; Headache; Hypertension; Metaraminol | 1965 |